Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Sudhan DR, Guerrero-Zotano A, Won H, Gonzalez Ericsson P, et al. Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers. Cancer Cell 2020;37:183-199.
PMID: 31978326


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016